Prostate Cancer Research Inc
EIN: 853336070 · Dover, DE · NTEE: H40
| Metric | Value |
|---|---|
| Total Revenue | $23K |
| Total Expenses | $421K |
| Net Assets | $-722,622 |
Is Prostate Cancer Research Inc Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About Prostate Cancer Research Inc
Prostate Cancer Research Inc (EIN: 853336070) is a nonprofit organization based in Dover, DE, classified under NTEE code H40. The organization reported total revenue of $23K and total assets of $31K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Prostate Cancer Research Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Prostate Cancer Research Inc is a micro nonprofit that has been operating for 5 years, with 3 years of IRS 990 filings on record (2021–2023). Revenue has grown at a compound annual rate of -17.2%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $23K |
| Total Expenses | $421K |
| Surplus / Deficit | $-398,052 |
| Total Assets | $31K |
| Total Liabilities | $753K |
| Net Assets | $-722,622 |
| Operating Margin | -1754.5% |
| Debt-to-Asset Ratio | 2465.3% |
| Months of Reserves | 0.9 months |
Financial Health Grade: D
In 2023, Prostate Cancer Research Inc reported a deficit of $398K with expenses exceeding revenue, holds 0.9 months of operating reserves (limited), has a debt-to-asset ratio of 2465.3% (high leverage).
Financial Trends
Over 3 years of filings (2021–2023), Prostate Cancer Research Inc's revenue has declined at a compound annual growth rate (CAGR) of -17.2%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2022 | -100.0% | +64.0% | +71.2% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1200 |
| IRS Ruling Date | 2021 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Prostate Cancer Research Inc has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Prostate Cancer Research Inc with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $398K, with expenses exceeding revenue.
- Debt-to-asset ratio: 2465.3%.
Frequently Asked Questions about Prostate Cancer Research Inc
Is Prostate Cancer Research Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, Prostate Cancer Research Inc (EIN: 853336070) insufficient data. 0 red flags identified, 0 strengths noted.
How does Prostate Cancer Research Inc spend its money?
Detailed spending breakdown data is not yet available for Prostate Cancer Research Inc. Check back for updated IRS 990 analysis.
Are donations to Prostate Cancer Research Inc tax-deductible?
Prostate Cancer Research Inc is registered as a tax-exempt nonprofit (EIN: 853336070). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is Prostate Cancer Research Inc located?
Prostate Cancer Research Inc is headquartered in Dover, Delaware and files with the IRS under EIN 853336070. It is classified under NTEE code H40.
How many years of IRS 990 filings does Prostate Cancer Research Inc have?
Prostate Cancer Research Inc has 3 years of IRS 990 filings on record at NonprofitSpending. Additional filing years may become available as the IRS releases new data. The most recent filing shows $23K in total revenue.
Filing History
IRS 990 filing history for Prostate Cancer Research Inc showing financial trends over 3 years of public records:
Over 3 years of IRS 990 filings (2021–2023), Prostate Cancer Research Inc's revenue has declined by 31.5%, moving from $33K to $23K. Total assets increased by 79% over the same period, from $17K to $31K. Total functional expenses rose by 134.9%, from $179K to $421K. In its most recent filing year (2023), Prostate Cancer Research Inc reported a deficit of $398K, with expenses exceeding revenue. The organization holds $753K in liabilities against $31K in assets (debt-to-asset ratio: 2465.3%), resulting in net assets of $-722,622.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $23K | $421K | $31K | $753K | — | — |
| 2022 | $0 | $294K | $29K | $354K | — | View 990 |
| 2021 | $33K | $179K | $17K | $163K | — | — |
Year-by-Year Financial Summary
- 2023: Revenue of $23K, expenses of $421K, and assets of $31K.
- 2022: Revenue of $0, expenses of $294K, and assets of $29K (revenue -100.0% year-over-year).
- 2021: Revenue of $33K, expenses of $179K, and assets of $17K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Prostate Cancer Research Inc:
Data Sources and Methodology
This transparency report for Prostate Cancer Research Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.